Gilead clears European hurdle for next-generation hepatitis C drug By: San Francisco Business Times via Business Journals September 26, 2014 at 13:24 PM EDT European drug gatekeepers Friday blessed Gilead Sciences Inc.'s next-generation hepatitis C combination, the company said... Read More >>